BUB1 and CDK4/6 Dual Inhibition Increases Radiation Sensitivity in Glioblastoma, Lung Cancer, and Triple-Negative Breast Cancer.

BAY-1816032 - Bayer

Kisqali (ribociclib) - Novartis

Verzenio (abemaciclib) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42792682

Anthony J Davis; Asya Haider Muratoglu; Benjamin Movsas; Corey Speers; Farzan Siddiqui; Rhea Hede-Sakhardande; Shivani Thoidingjam; Shyam Nyati; Stephen L Brown; Sunita Ghosh; Sushmitha Sriramulu

Sep 27, 2026